NCT00466557|Completed
Plasmodium Resistance in A. Gambiae
Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae
Loading search results
Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae
Sponsor study identifier
observational
40
1 country
1
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 30, 2012
Actual (reported)Study Completion
Not reported
Date not reportedThe purpose of this study is to find new ways to control malaria by looking at mosquitoes infected with the disease. Knowledge of the genetics that affect the spread of malaria by mosquitoes will help in developing control strategies. A small amount of blood from infected humans will be used to infect the mosquitoes. No contact will occur between the human subject and the mosquito. Study participants will be divided into 2 groups of 20, for a total of 40 children, ages 5-10, in Burkina Faso, West Africa. Each subject will be screened by finger-prick once per month, from June through October, until they reach a maximum age of 10. Two positive subjects of the 40 screened will be asked to donate about 1 teaspoon of blood, which will be used to feed and infect the mosquitoes. Study participants will be involved in study related procedures for a maximum of 5 years.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 26, 2007
Actual (reported)April 27, 2007
Actual (reported)June 2007
Date type not reportedThis date has not been verified as actual or estimated.
April 30, 2012
Actual (reported)Centre National de Recherche et de Formation sur le Paludisme
West Africa, Burkina Faso
First Submitted
April 26, 2007
First Posted
April 27, 2007
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 30, 2012
Actual (reported)Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen
Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso
Contact the study team to confirm eligibility.
Last Updated
January 31, 2019
Record last verified: 2012-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: